AN2 Therapeutics (ANTX)

• Market cap: $173M
• 1 day: 1.05%
• 5 days: 14.25%
• 1 month: 7.37%
• 3 months: -3.8%
• 6 months: 325.66%
• Year to date: 333.33%
• 1 year: 307.63%
• 5 years: -68.77%
• 10 years: -68.77%
• Sector: Healthcare
• Industry: Biotechnology

About: AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Employees: 21